| LLY |
Eli Lilly and Company |
782.95B |
18.35% |
|
|
|
|
|
825.91 |
0.41% |
68.73% |
103.71% |
|---|
| BMY |
Bristol-Myers Squibb Company |
124.10B |
7.03% |
|
|
|
|
|
60.99 |
1.62% |
51.20% |
100.20% |
|---|
| NVS |
Novartis AG |
220.18B |
6.59% |
|
|
|
|
|
111.48 |
-0.97% |
25.57% |
99.35% |
|---|
| AMGN |
Amgen Inc. |
167.37B |
6.15% |
|
|
|
|
|
311.55 |
1.50% |
48.53% |
86.78% |
|---|
| AZN |
AstraZeneca PLC |
227.94B |
5.78% |
|
|
|
|
|
73.50 |
-0.39% |
49.15% |
92.89% |
|---|
| USBGFS7 |
US BANK MMDA - USBGFS 7 06/01/2031 |
|
5.21% |
|
|
|
|
|
|
|
|
|
|---|
| JNJ |
Johnson & Johnson |
399.65B |
5.17% |
|
|
|
|
|
165.84 |
1.30% |
31.55% |
81.35% |
|---|
| PFE |
Pfizer Inc. |
143.71B |
4.83% |
|
|
|
|
|
25.34 |
0.52% |
54.57% |
111.01% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
35.12B |
4.80% |
|
|
|
|
|
270.02 |
0.58% |
41.52% |
44.72% |
|---|
| ALKS |
Alkermes plc |
5.37B |
4.68% |
|
|
|
|
|
33.02 |
-0.57% |
55.46% |
91.81% |
|---|
| MRK |
Merck & Co., Inc. |
226.74B |
4.67% |
|
|
|
|
|
89.76 |
0.59% |
50.77% |
116.36% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
68.18B |
3.57% |
|
|
|
|
|
634.23 |
-0.49% |
56.82% |
106.08% |
|---|
| BIIB |
Biogen Inc. |
20.03B |
3.31% |
|
|
|
|
|
136.84 |
-1.11% |
58.80% |
91.93% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
4.80B |
3.08% |
|
|
|
|
|
30.17 |
-3.15% |
57.02% |
95.66% |
|---|
| CRSP |
CRISPR Therapeutics AG |
2.92B |
2.88% |
|
|
|
|
|
34.03 |
-8.00% |
78.44% |
102.95% |
|---|
| GSK |
GSK plc |
78.79B |
2.68% |
|
|
|
|
|
38.74 |
0.06% |
46.73% |
101.19% |
|---|
| BEAM |
Beam Therapeutics Inc. |
1.95B |
1.71% |
|
|
|
|
|
19.53 |
-12.07% |
63.92% |
100.08% |
|---|
| BCYC |
Bicycle Therapeutics plc |
586.33M |
1.44% |
|
|
|
|
|
8.49 |
-5.35% |
250.22% |
87.25% |
|---|
| REPL |
Replimune Group, Inc. |
750.89M |
1.25% |
|
|
|
|
|
9.75 |
-6.16% |
122.01% |
25.44% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
736.01M |
1.16% |
|
|
|
|
|
7.11 |
-11.90% |
84.48% |
97.00% |
|---|
| HLN |
Haleon plc |
46.48B |
0.95% |
|
|
|
|
|
10.29 |
0.49% |
54.43% |
67.97% |
|---|
| VNDA |
Vanda Pharmaceuticals Inc. |
267.67M |
0.87% |
|
|
|
|
|
4.59 |
-2.13% |
86.92% |
55.58% |
|---|
| LTRN |
Lantern Pharma Inc. |
38.18M |
0.67% |
|
|
|
|
|
3.54 |
-0.28% |
118.31% |
31.28% |
|---|
| SDZNY |
Sandoz Group AG |
|
0.56% |
|
|
|
|
|
|
|
|
|
|---|
| GEHC |
GE HealthCare Technologies Inc. |
36.91B |
0.53% |
|
|
|
|
|
80.71 |
0.87% |
62.38% |
94.80% |
|---|
| GALT |
Galectin Therapeutics Inc. |
76.02M |
0.42% |
|
|
|
|
|
1.2200 |
-19.74% |
302.34% |
31.18% |
|---|
| TSVT |
2seventy bio, Inc. |
258.55M |
0.35% |
|
|
|
|
|
4.94 |
-0.20% |
368.39% |
63.66% |
|---|
| VTRS |
Viatris Inc. |
10.40B |
0.31% |
|
|
|
|
|
8.71 |
0.35% |
30.87% |
111.75% |
|---|
| ALLO |
Allogene Therapeutics, Inc. |
317.21M |
0.29% |
|
|
|
|
|
1.4600 |
-5.81% |
677.77% |
77.82% |
|---|
| EDIT |
Editas Medicine, Inc. |
96.25M |
0.27% |
|
|
|
|
|
1.1600 |
-7.20% |
146.68% |
65.74% |
|---|
| PACB |
Pacific Biosciences of California, Inc. |
351.47M |
0.15% |
|
|
|
|
|
1.1800 |
3.51% |
120.73% |
13.94% |
|---|
| Cash&Other |
Cash & Other |
|
0.14% |
|
|
|
|
|
|
|
|
|
|---|
| BLUE |
bluebird bio, Inc. |
47.54M |
0.10% |
|
|
|
|
|
4.88 |
19.61% |
122.15% |
9.14% |
|---|
| MURA |
Mural Oncology plc |
21.71M |
0.05% |
|
|
|
|
|
1.2600 |
6.78% |
394.12% |
55.50% |
|---|
| SLRX |
Salarius Pharmaceuticals, Inc. |
1.32M |
0.04% |
|
|
|
|
|
0.7540 |
-12.53% |
N/A |
N/A |
|---|
| 2368714D |
Pathos AI Inc |
|
N/A |
|
|
|
|
|
|
|
|
|
|---|